Gemcitabine-induced supraventricular tachycardia.

摘要: The superior toxicity profile is one of the major reasons for widespread use gemcitabine in cancer treatment. Bone marrow suppression most common side effect, while non-hematological events are relatively infrequent. Cardiac a rare complication and cardiac arrhythmia even rarer. We report case 67-year-old woman with metastatic breast without history or ischemic heart disease who developed supraventricular tachycardia. symptoms had started immediately after responded poorly to treatment was eventually controlled by oral propranolol five days admission. present suggests that tachycardia may be triggered underlying significant resistant conventional therapy.